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ABSTRACT 
  
We studied the behaviour of 8-azido-2’-deoxyadenine and 8-bromo-2’-deoxyadenosine 
in aqueous solutions of ammonia and primary and secondary amines. Unexpectedly, 8-
Azido-2’-deoxyadenosine is converted to 8-amino-2'-deoxyadenosine in excellent 
yields. The use of this reaction for the preparation of 8-aminoadenine derivatives 
needed for the preparation of oligonucleotides carrying 8-aminoadenine is discussed.  
 
 
INTRODUCTION 
 
Purine nucleosides carrying azido groups at the nucleobase are important intermediates 
for the preparation of photoreactive nucleotides used in the study of protein-nucleic acid 
interactions.1 Moreover, they are useful intermediates in the synthesis of modified 
nucleosides like purine nucleosides carrying amino groups.2,3 For this purpose, a 
nucleoside carrying a halogen (Cl or Br) is reacted with sodium or lithium azide 
yielding the azidopurine, which is reduced by catalytic hydrogenation3 or reducing 
metals.2,4  
Oligonucleotides carrying 8-aminoadenine form very stable triple helices5-8 and 
parallel-stranded structures.8,9 The introduction of the amino group at position 8 
increases the stability of Hoogsteen structures owing to the combined effect of the gain 
of one Hoogsteen purine-pyrimidine H-bond and the tendency of the amino group to be 
integrated into the ‘spine of hydration’ located in the minor-major groove of the triplex 
structure.6 8-Amino-2’-deoxyadenine (3) was prepared using the following three-step 
protocol: bromination of dA, nucleophilic displacement to form the 8-azidonucleoside 
(2) and catalytic hydrogenation of 8-azido-2’-deoxyadenine (2) (SCHEME I).3 
Moreover, 8-azido-2’-deoxyadenosine (2) has been incorporated into 
oligonucleotides.10,11 8-Azido-2’-deoxyadenosine (2) is partially decomposed during the 
ammonia treatment used for the removal of protecting groups of oligonucleotides (conc. 
NH3, room temperature and 55 ºC). Fàbrega et al. described the formation of one single 
side product, 8-amino-2’-deoxyadenosine (3)10 and Liu et al. reported two possible side 
compounds: 8-amino-2’-deoxyadenosine (3) and 8-oxo-2’-deoxyadenosine (4).11 These 
two products are also formed during the ammonia treatment of oligonucleotides 
carrying 8-bromo-2’-deoxyadenine.12  
 
SCHEME 1: Synthesis of the 8-substituted 2’-deoxyadenosine derivatives used in this 
study. 
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We analysed the behaviour of 8-azido-2’deoxyadenosine (2) in ammonia solutions and 
in solutions of primary and secondary amines. We confirmed that only 8-amino-2’-
deoxyadenosine (3) is formed and that the reaction of compound 2 with volatile primary 
amines is useful for the preparation of 8-amino-2’-deoxyadenine without 
hydrogenation. 
 
 
RESULTS AND DISCUSSION 
 
8-Bromo-2’-deoxyadenosine (1, SCHEME I) was prepared by bromination of dA13 
(73% yield). Reaction of 1 with sodium azide3, 14 gave 8-azido-2’-deoxyadenosine (2) in 
75% yield. Hydrogenation3 of compound 2 using Pd/ activated charcoal as catalyst gave 
8-amino-2’-deoxyadenosine (3) in 90% yield. Finally, starting from compound 1, 8-
oxo-2’-deoxyadenosine (4) was prepared as described elsewhere.13 Reverse-phase 
HPLC using diode-array detector allowed the separation and rapid identification of 
compounds 1-4. The elution order from more polar to less polar was as follows: 8-
amino-dA (3), 8-oxo-dA (4), 8-azido-dA (2) and 8-bromo-dA (1). 
Aliquots of 8-azido-dA (2) and 8-bromo-dA (1) were treated with 3 ml of 30% aqueous 
ammonia and 5M methanolic ammonia at 55ºC. The reaction of 8-azido-dA (2) with 
aqueous ammonia gave only 8-amino-dA (3). A 45% conversion was observed after 20 
hours, 62% after 3 days and 90% after 6 days (TABLE 1). The product was isolated and 
characterized by 1H and 13C-RMN. Compound 2 decomposed slowly in methanolic 
ammonia (<50% after 6 days, TABLE 1). On the other hand, treatment of 8-bromo-dA 
(1) with 30% aqueous ammonia and 5M methanolic ammonia at 55ºC gave small 
amounts of a mixture of 8-amino-dA (3) and 8-oxo-dA (4) (20% decomposition with 
aqueous ammonia after 16 hours at 55ºC, TABLE 1).  
These results were in agreement with the behaviour of compounds 1 and 2 in 
oligonucleotides,10-12 except that 8-oxo-dA (4) was not formed in the treatment of 
compound 2 with aqueous ammonia. Unexpectedly, the formation of 8-amino-dA (3) 
from compound 2 was clean and faster than the formation of compound 3 from 
compound 1. To gain more information on this reaction, compound 3 was also treated 
with an aqueous solution of several amines.   
 
Table 1: Composition of the reaction mixtures obtained after the treatment of 
compounds 1 and 2 with amine solutions at 55ºC. 
Compound Treatment time Composition of the reaction mixture (%) 
   2 3 1 4 5 
2 30% aq.NH3 16 h 55 45 -- -- -- 
  3 days 38 62 -- -- -- 
  6 days 10 90 -- -- -- 
2 5M NH3/MeOH 16 h 96 4 -- -- -- 
  3 days 65 35 -- -- -- 
  6 days 53 47 -- -- -- 
1 30% aqNH3 5 h -- -- 80 7 13 
1 5M NH3/MeOH 16 h -- -- 80# 9# 7# 
2 40% 
aqCH3NH2 
5 h 0 100 -- -- -- 
2 30% aq 
dimethylamine 
16 h 30 70 -- -- -- 
2 1M aq 
piperidine 
16 h 0 100 -- -- -- 
2 1M aq 1,6-
diaminohexane 
5 h 0 100 -- -- -- 
1 1M aq 1,6-
diaminohexane 
16 h -- -- 0 20 80 
#In addition 4% of a product eluting at 9.8 min (UV max 260 nm) was observed. Most 
probably the product was 8-methoxy-2’-deoxyadenosine. 
 
 
 
 Aliquots of 8-azido-dA (2) were treated with solutions of amines (SCHEME II) at 55ºC. 
The reaction of 8-azido-dA (2) with 40% aqueous methylamine gave complete 
conversion to 8-amino-dA (3) in less than 5 hours. Reaction with a 30% aqueous 
solution of dimethylamine gave 70% conversion to 8-amino-dA after 16 hours. 
Treatment of compound 2 with 1M aqueous solutions of piperidine and 1,6-
diaminohexane gave also gave 8-amino-dA (3) at 55ºC after 16 and 5 hours 
respectively. The identity of the product was confirmed by HPLC analysis and by 
isolation of the products resulting from the reactions and analysis of their 1H and 13C-
NMR spectra.  
 
SCHEME 2: Treatment of 8-azido-2’-deoxyadenosine with amines. 
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On the other hand, treatment of 8-bromo-dA (1) with hexane-1,6-diamine gave the 
expected mixture of the products resulting from the attack of both nucleophiles present 
in the mixture: 8-oxo-dA and 8-(6-aminohexyl)amino-dA (SCHEME 3), in agreement 
with the results obtained during the preparation of 8-N-aminosusbtituted dA 
derivatives.3,15  
 
 
SCHEME 3: Products obtained from the treatment of 8-bromo-2’-deoxyadenosine with 
a primary amine.  
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These data reveal a distinct behaviour of compounds 1 and 2 on aqueous amine 
solutions. The bromo derivative suffers a nucleophillic displacement by the amine and 
water, while the azido derivative is converted to the amino derivative (3) regardless of 
the amine present in the reaction and without interference with water. The reaction in 
the presence of primary amines is faster than in the presence of secondary amines, 
which is faster than in the presence of ammonia. This suggests the involvement of the 
amine in the thermal decomposition of the azido group to the nitrene intermediate, 
which later abstracts hydrogen from the environment to give the 8-aminopurine.16  
The scope of this reaction was assayed with several purine ribonucleosides carrying 
azido groups. As expected the treatment of ribonucleoside 8-azidoadenosine (6) with 
40% aqueous methylamine gave 8-aminoadenosine (7) (SCHEME 4). However, 
treatment of 6-azido-2-aminopurine riboside (8) and 6-azidopurine riboside (10) 
resulted in the addition of methylamine at position 6 of the purine with the subsequent 
displacement of the azido group (compounds 7 and 9) together with some 
decomposition products. In these cases, the azido group is in the tetrazolo tautomeric 
form (absence of an IR band in the region of 2000-2200 cm-1 and presence of an intense 
band in the 1700-1500 cm-1 region)17,18 and the nitrene is not formed. The reaction 
observed with compound 2 is only possible when the azido group is at position 8. 
Finally, we tested the reaction of compound 2 with amines for preparative purposes. We 
selected the inexpensive 40% aqueous methylamine solution because it allowed the fast 
formation of the desired compound 3 was very fast, and the amine was volatile. Several 
reactions on a 1-5 gram scale gave the desired compound in quantitative yields. The 
product resulting from the evaporation of methylamine was pure enough to perform the 
protection of the amino groups with the dimethylformamidine19,20 groups needed for the 
preparation of oligonucleotides carrying 8-amino-2’-deoxyadenosine. The DMT-
protected phosphoramidite derivative as well as oligonucleotides carrying 8-amino-2’-
deoxyadenosine were prepared as described elsewhere.5,6  
 
SCHEME 4: Products obtained from the treatment of the ribonucleosides carrying azido 
groups with methylamine. 
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EXPERIMENTAL SECTION 
 
General Methods. Solvents, including those of HPLC grade, were from SDS and E. 
Merck. Reagents were from Aldrich and Fluka and were used without further 
purification. Analytical TLC was run on aluminium sheets coated with silica gel 60 F254 
from Merck. Silica gel column chromatography was performed with Chromatogel 60 A 
C.C. (40-60 microns, 230-400 mesh, SDS). 8-Bromo-2’-deoxyadenosine (1),13 8-azido-
2’-deoxyadenosine (2),3,14 8-amino-2’-deoxyadenosine (3)3 and 8-oxo-2’-
deoxyadenosine (4)13 were prepared as described. 8-Bromoadenosine, 2-amino-6-
chloro-9-β-D-ribofuranosylpurine, and 6-chloro-9-β-D-ribofuranosylpurine were 
obtained from Pharma-Waldhof GmbH (Düsseldorf, Germany). N6-methyladenosine 
(11) was purchased from Sigma. 
 
Instrumental. 1H-NMR (250 MHz) and 13C-NMR (63 MHz) spectra were recorded on a 
Brüker AM-250. HPLC chromatography was performed on an HPLC Shimadzu 
equipped with a diode array detector. 
 
Treatment of 8-amino-2'-deoxyadenosine and 8-bromo-2'-deoxyadenosine with 
ammonia and amine aqueous solutions. 50 mg aliquots of 8-amino-2'-deoxyadenosine 
and 8-bromo-2'-deoxyadenosine were placed in screw-cap tubes and 3 ml of the 
appropriate ammonia or amine solutions was added. The mixtures were heated to 55ºC 
for a period of time between 5 hours and 6 days, allowed to cool to room temperature 
and evaporated to dryness. The residues were analysed by HPLC. HPLC conditions 
were as follows: Solution A, 0.1 M aqueous triethylammonium acetate pH 6.5 / 
acetonitrile (95:5); solution B, 0.1 M aqueous triethylammonium acetate pH 6.5 / 
acetonitrile (3: 7); Column PRP-1 (Hamilton, 10  μm) 250x 10 mm; flow rate, 3 ml/ min 
and;  20 min linear gradient from 0% B to 50% B. Retention time for 8-amino-dA: 7.4 
min; for 8-oxo-dA: 8.1 min; for 8-azido-dA: 11.3 min and for 8-bromo-dA: 11.4 min. 
UV maximum for 8-amino-dA: 276 nm; for 8-oxo-dA 272 nm; for 8-azido-dA 284 nm 
and for 8-bromo-dA 267 nm. Reaction products were also identified by comparison of 
the chemical shift of the C-8 at 13C-NMR spectra with published spectra.10,13 
 
8-Azidoadenosine (6). Compound 6 was prepared as described14 with minor 
modifications. 250 mg (0.72 mmol) of 8-bromoadenosine was treated with 148 mg 
(2.17 mmol) of sodium azide in 5 ml of dimethylformamide (DMF) at 60ºC for 16 h. 
The solution was cooled and concentrated to dryness. The resulting product was 
crystallized from water-methanol (MeOH) giving 130 mg (59% yield) of a white solid. 
UV (max, pH 6.5) 284 nm. IR (KBr, cm-1): intense bands at 2154 and 2043.  1H-NMR 
(DMSO-d6): 8.05 (s, 1H, H-2), 7.31 (wide s, 2H, amino), 5.60 (d, 1H, OH), 5.38 (m, 
2H, OH and H-1’), 5.15 (d, 1H, OH), 4.84 (m, 1H, H-2’), 4.18 (m, 1H, H-3’), 3.9 (m, 
1H, H-4’), 3.58 (m, 2H, H-5’). 13C-NMR (DMSO-d6): 154.7 (C6), 156.8 (C2), 149.6 
(C4), 144.6 (C8), 117.5 (C5), 87.8 (C1’), 86.5 (C4’), 71.5 (C3’), 71.0 (C2’), 62.3 (C5’). 
MS (electrospray): found 309.8 (M+H+) calculated for C10H12N8O4 308.3. 
 
 
6-Azido-2-amino-9-β-D-ribofuranosylpurine (8). 300 mg (1 mmol) of 8-chloro-2-
amino-9-β-D-ribofuranosylpurine was treated with 211 mg (3 mmol) of sodium azide in 
7 ml of DMF at 60ºC for 16 h. The solution was cooled and concentrated to dryness. 
The resulting product was crystallized from water-methanol (MeOH) giving 200 mg 
(65% yield) of a white solid. UV (max, pH 6.5) 270, 300 nm. IR (KBr, cm-1): absence 
of bands in the region 2200-2000, intense band at 1694. 1H-NMR (DMSO-d6): 8.4 (m, 
3H, H-8 and amino), 5.91 (d, 1H, H-1’), 5.45 (d, 1H, OH), 5.20 (d, 1H, OH), 5.02 (t, 
1H, OH), 4.5 (m, 1H, H-2’), 4.18 (m, 1H, H-3’), 3.9 (m, 1H, H-4’), 3.6 (m, 2H, H-5’). 
13C-NMR (DMSO-d6): 146.3 (C6), 145.1 (C2), 144.1 (C4), 138.5 (C8), 112.4 (C5), 87.3 
(C1’), 85.7 (C4’), 74.3 (C3’), 70.2 (C2’), 61.4 (C5’). MS (electrospray): found 309.0 
(M+H+) calculated for C10H11N8O4 307.2.  
 
6-Azido-9-β-D-ribofuranosylpurine (10). 500 mg (1.75 mmol) of 8-chloro-9-β-D-
ribofuranosylpurine was treated with 357 mg (5.2 mmol) of sodium azide in 10 ml of 
DMF at 60ºC for 16 h. The solution was cooled and concentrated to dryness. The 
resulting product was crystallized from water-methanol (MeOH) giving 110 mg (21% 
yield) of a white solid. UV (max, pH 6.5) 290 nm. IR (KBr, cm-1): absence of bands in 
the region 2200-2000, intense band at 1645. 1H-NMR (DMSO-d6): 10.1 (s 1H), 8.9 (s, 
1H), 6.11 (d, 1H, H-1’), 5.62 (d, 1H, OH), 5.29 (d, 1H, OH), 5.1 (t, 1H, OH), 4.53 (m, 
1H, H-2’), 4.15 (m, 1H, H-3’), 3.98 (m, 1H, H-4’), 3.64 (m, 2H, H-5’). 13C-NMR 
(DMSO-d6): 145.6 (C6), 142.8 (C2), 142.1 (C4), 136.3 (C8), 121 (C5), 88.5 (C1’), 85.9 
(C4’), 74.8 (C3’), 70.2 (C2’), 61.1 (C5’). MS (electrospray): found 293.9 (M+H+) 
calculated for C10H11N7O4 293.2. 
 
Treatment of ribonucleosides carrying azido groups with methylamine. 
50 mg aliquots of azido-ribonucleosides (6, 8, 10) were placed in screw-cap tubes and 3 
ml of 40% aqueous methylamine was added. The mixtures were heated to 60ºC for a 
period of time between 16 and 48 h, allowed to cool to room temperature and 
evaporated to dryness. The residues were analysed by HPLC as described above. 
Retention time (UV maxima) for compound 6: 9.6 min (284 nm); for compound 7: 6.4 
min (272 nm); for compound 8: 7.5 min (270, 300nm); for compound 9: 2.7 min (242 
nm); for compound 10: 8.2 min (290 nm) and for compound 11: 3.8 (250 nm).  
The reaction with compound 6 was completed after 16 h, giving one single product that 
was characterized as 8-aminoadenosine (7)14. 1H-NMR (DMSO-d6): 7.89 (s, 1H, H-2), 
6.54 (m, 2H, amino), 5.82 (d, 1H, H-1’), 4.64 (m, 1H, H-2’), 4.12 (m, 1H, H-3’), 3.9 (m, 
1H, H-4’), 3.58 (m, 2H, H-5’). 13C-NMR (DMSO-d6): 152.6 (C6), 151.8 (C2), 149.5 
(C4), 148.5 (C8), 117.4 (C5), 86.8 (C1’), 86.0 (C4’), 71.1 (C3’ and C2’), 62.0 (C5’). 
MS (electrospray): found 283.4 (M+H+) calculated for C10H14N6O4 282.2. 
The reaction with compound 8 was completed after 48 h, giving one major product that 
was characterized as 2-amino-N6-methyladenosine (9)21 together with some minor 
products that were not characterized. 1H-NMR (DMSO-d6): 7.9 (s, 1H, H-8), 5.49 (d, 
1H, H-1’), 4.32 (m, 1H, H-2’), 4.12 (m, 1H, H-3’), 3.86 (m, 1H, H-4’), 3.58 (m, 2H, H-
5’), 2.7 (s, 3H, CH3). 13C-NMR (DMSO-d6): 156.5 (C6), 155.6 (C2), 150.7 (C4), 133.7 
(C8), 112.7 (C5), 87.6 (C1’), 84.4 (C4’), 74.6 (C3’), 69.6 (C2’), 60.6 (C5’), 27.9 (CH3). 
MS (electrospray): found 297.5 (M+H+) calculated for C11H16N6O4 296.3. 
The reaction with compound 10 was completed after 16 h, giving several products. One 
of the products was characterized as N6-methyladenosine (11) by comparison with the 
commercially available product and mass spectrometry (MS (electrospray): found 284.5 
(M+H+) calculated for C11H15N5O4 281.2).  
 
Synthesis of 8-amino-N,N-bis(dimethylaminomethyliden)-2’-deoxyadenosine 
In a screw-cap tube, 4.62 g of 8-azido-2’-deoxyadenosine3,14 was dissolved with 20 ml 
of 40% aqueous methylamine solution and 2 ml of dioxane. The solution was heated 
overnight to 55ºC. It was then cooled to room temperature and concentrated to dryness, 
yielding an oil that was used in the following step without purification. Purity assessed 
by HPLC (< 95%). 
The product described above (approx. 17.5 mmol) was dissolved in 250 ml of DMF and 
treated with 12.1 ml of dimethyl acetal of the DMF. The solution was stirred overnight 
at room temperature and then evaporated to dryness. The resulting product was purified 
by silica gel chromatography (0-20% methanol in dichloromethane), yielding 5.4 g of 
the desired compound (82% yield). Physical and spectral data were as described 
elsewhere.5,6  
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